156 - Miscellaneous Bacterial Infections with Cutaneous Manifestations Flashcards
Bioweapon potential A
Anthrax
Tularemia
Plague
Bioweapon potential B
Brucellosis
Glanders (Burkholderia mallei)
Melioidiosis (Burkholderia pseudomallei)
BBB
Gram-positive bacteria
Bacillus anthrasis Listeria monocytogenes Erysipelothrix rhusiopathiae Streptococcus iniae Corynebacterium diphtheriae
Gram-negative bacteria
Francisella tularensis Yersinia pestis Brucella Burkholderia mallei Pasteurella multocia Streptobacillus moniliformis Spirillum minus Mycoplasma Vibrio vulfinicus Aeromonas hydrophila Burkholderia pseudomallei Chromobacterium violaceum
Worldwide, especially developing agrarian areas
Painless edematous plaque with central black ulcer or eschar; “malignant pustule”; “malignant edema”
Goats, sheep, cattle, or products made from them
Anthrax
Etiologic agent: Anthrax
Bacillus anthrasis
Anthrax route of inoculation
Cutaneous
Inhalational
GI
Injectional
_____ anthrax has a distinct clinical course because it presents without an eschar; more virulent with a much higher mortality rate
Injectional
Injectional anthrax resulted from exposure to
Contaminated heroin
Major virulence factors of Bacillus anthracis
Poly-gamma-D-glutamic acid capsule
Tripartite anthrax toxin
The tripartite anthrax toxin contains 3 proteins
Protective antigen
Lethal factor
Edema factor
Best target for anthrax vaccines or immunotherapy
Protective antigen
Y/N: Lesional progression in anthrax is caused by the bacteria and is responsive to antibiotic therapy
No - caused by toxins and is unaffected by antibiotic therapy
Naturally occurring anthrax is treated with
Penicillin or doxycycline
Recommended initial treatment for confirmed or suspected bioterrorism-associated anthrax
Fluoroquinolone
Humanized monoclonal antibody that has specificity for the bacterial protective antigen, to be used in cases of inhalational anthrax
Raxibacumab
Infectious propagule in anthrax
Spore
Y/N: Anthrax is not transmitted from person-to-person
Yes
Y/N: Untreated cutaneous anthrax, particularly if nonedematous, is a largely self-resolving disease
Yes
Y/N: Patients with injectional, inhalational, or GI anthrax should be placed in intensive care units
Yes
Temperate and gold regions, North America, Europe
Ulceroglandular: painful papule that ulcerates and forms eschar
Tick bites, lagomorphs (rabbits and hares), rodents
Tularemia
Etiologic agent: Tularemia
Francisella tularensis
6 major clinical presentations of tularemia
Glandular Ulceroglandular Oculoglandular Oropharyngeal Typhoidal Pneumonic
Most common form of tularemia in the US
Ulceroglandular